Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0W1JJ
|
|||
| Former ID |
DNCL003550
|
|||
| Drug Name |
GS-9669
|
|||
| Synonyms |
Radalbuvir; GS-9669; UNII-273K4V0SPC; 273K4V0SPC; 1314795-11-3; Radalbuvir [INN]; SCHEMBL19607380; SCHEMBL15252930; SCHEMBL15252929; SCHEMBL12444696; CHEMBL3121539; SB16766; DB12065; 2-Thiophenecarboxylic acid, 5-(3,3-dimethyl-1-butyn-1-yl)-3-((cis-4-hydroxy-4-((((3S)-tetrahydro-3-furanyl)oxy)methyl)cyclohexyl)(((1R)-4-methyl-3-cyclohexen-1-yl)carbonyl)amino)-; 5-(3,3-dimethylbut-1-ynyl)-3-[[4-hydroxy-4-[[(3S)-tetrahydrofuran-3-yl]oxymethyl]cyclohexyl]-[(1R)-4-methylcyclohex-3-ene-1-carbonyl]amino]thiophene-2-carboxylic
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Chronic HCV-1 infection [ICD-11: 1E51.1; ICD-10: B18.2] | Phase 2 | [1] | |
| Company |
GILEAD
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C30H41NO6S
|
|||
| Canonical SMILES |
CC1=CCC(CC1)C(=O)N(C2CCC(CC2)(COC3CCOC3)O)C4=C(SC(=C4)C#CC(C)(C)C)C(=O)O
|
|||
| InChI |
1S/C30H41NO6S/c1-20-5-7-21(8-6-20)27(32)31(25-17-24(11-13-29(2,3)4)38-26(25)28(33)34)22-9-14-30(35,15-10-22)19-37-23-12-16-36-18-23/h5,17,21-23,35H,6-10,12,14-16,18-19H2,1-4H3,(H,33,34)/t21-,22?,23-,30?/m0/s1
|
|||
| InChIKey |
MUICUPWICXUNRS-UVXQUXCMSA-N
|
|||
| CAS Number |
CAS 1314795-11-3
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01260350) Open-Labeled Study of PSI-7977 and RBV With and Without PEG-IFN in Treatment-Naive Patients With HCV GT2 or GT3. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.